ANGPTL8 and metabolic dysfunction-associated steatotic liver disease: Many serum biomarkers have been explored for use in the diagnosis and follow-up of NAFLD, with serum angiopoietin-like protein-8 (ANGPTL-8) levels being one of the most promising.